MX9200146A - Composiciones farmaceuticas deglutibles - Google Patents

Composiciones farmaceuticas deglutibles

Info

Publication number
MX9200146A
MX9200146A MX9200146A MX9200146A MX9200146A MX 9200146 A MX9200146 A MX 9200146A MX 9200146 A MX9200146 A MX 9200146A MX 9200146 A MX9200146 A MX 9200146A MX 9200146 A MX9200146 A MX 9200146A
Authority
MX
Mexico
Prior art keywords
pharmaceutical compositions
swallowable
swallowable pharmaceutical
compositions
pharmaceutical
Prior art date
Application number
MX9200146A
Other languages
English (en)
Inventor
Francis Bernard Chapura
Sekhar Mitra
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of MX9200146A publication Critical patent/MX9200146A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
MX9200146A 1991-01-14 1992-01-14 Composiciones farmaceuticas deglutibles MX9200146A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/641,030 US5128140A (en) 1991-01-14 1991-01-14 Swallowable pharmaceutical compositions

Publications (1)

Publication Number Publication Date
MX9200146A true MX9200146A (es) 1992-07-01

Family

ID=24570661

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9200146A MX9200146A (es) 1991-01-14 1992-01-14 Composiciones farmaceuticas deglutibles

Country Status (5)

Country Link
US (1) US5128140A (es)
AU (1) AU1252592A (es)
IE (1) IE920096A1 (es)
MX (1) MX9200146A (es)
WO (1) WO1992011849A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2087596A1 (en) * 1990-07-20 1992-01-21 John Rhodes Products and processes for the treatment of the alimentary canal
GB9120131D0 (en) * 1991-09-20 1991-11-06 Glaxo Group Ltd Medicaments
DE69228738D1 (de) * 1991-12-06 1999-04-29 Glaxo Group Ltd Zusammensetzungen zur Behandlung von entzündlichen Zuständen oder Analgesie, die Ranitidin Wismuth Citrat und einen NSAID enthalten
EP0995447A1 (en) * 1993-09-09 2000-04-26 Takeda Chemical Industries, Ltd. Formulation comprising antibacterial substance and antiulcer substance
KR100399524B1 (ko) * 1995-02-06 2004-04-13 아스트라제네카 악티에볼라그 신규경구제약학상제형
SE9500422D0 (sv) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
WO1998022118A1 (en) * 1996-11-22 1998-05-28 The Procter & Gamble Company Compositions for the treatment of gastrointestinal disorders containing bismuth and nsaid
US20030124141A1 (en) * 1997-04-01 2003-07-03 Rainer Haas Helicobacter polypeptides and corresponding polynucleotide molecules
JP2001523954A (ja) * 1997-04-01 2001-11-27 メリウクス オラバクス ７６ ｋＤａ、３２ ｋＤａ、および５０ ｋＤａヘリコバクター（Ｈｅｌｉｃｏｂａｃｔｅｒ）ポリペプチドおよび対応するポリヌクレオチド分子
US20020026035A1 (en) * 1997-04-01 2002-02-28 Harold Kleanthous Helicobacter ghpo 1360 and ghpo 750 polypeptides and corresponding polynucleotide molecules
US20030158396A1 (en) * 1997-07-29 2003-08-21 Harold Kleanthous Identification of polynucleotides encoding novel helicobacter polypeptides in the helicobacter genome
US9457048B2 (en) * 2008-02-05 2016-10-04 Wellosophy Corporation Absorbent ingestible agents and associated methods of manufacture and use
CN106215195B (zh) * 2016-07-27 2019-09-17 上海安翰医疗技术有限公司 消化道动力检测胶囊及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0059597B1 (en) * 1981-02-27 1986-04-23 Imperial Chemical Industries Plc Guanidino-substituted heterocyclic derivatives having histamine h-2 antagonist activity
US4801608A (en) * 1981-09-22 1989-01-31 Gist-Brocades N. V. Bismuth containing composition and method for the preparation thereof
US4801454A (en) * 1986-07-17 1989-01-31 The Proctor & Gamble Company Processes for making colored pharmaceutical compositions
ATE81011T1 (de) * 1987-03-09 1992-10-15 Procter & Gamble Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen.
CH679582A5 (es) * 1988-07-18 1992-03-13 Glaxo Group Ltd
FI910088A (fi) * 1990-01-09 1991-07-10 Gist Brocades Nv Oral farmaceutisk komposition.

Also Published As

Publication number Publication date
WO1992011849A1 (en) 1992-07-23
IE920096A1 (en) 1992-07-15
US5128140A (en) 1992-07-07
AU1252592A (en) 1992-08-17

Similar Documents

Publication Publication Date Title
EE03108B1 (et) Farmatseutiline kompositsioon
FI981777A (fi) Farmaseuttinen ainekoostumus
DK0585252T3 (da) Farmaceutiske formuleringer
DK0515312T3 (da) Farmaceutisk præparat
NO923127D0 (no) Farmasoeytisk kombinasjonsformulering
FI921060A (fi) Farmaceutiska aerosolformuleringar
DE4291156T1 (de) Verbesserte pharmazeutische Zusammensetzungen
PT589843E (pt) Composicoes farmaceuticas contendo ciclosporinas
MX9200622A (es) Composicion farmaceutica
MX9200146A (es) Composiciones farmaceuticas deglutibles
IT1290797B1 (it) Composizioni farmaceutiche stabilizzate
DK0511991T3 (da) Farmaceutisk formulering
ITMI913510A1 (it) Composizioni farmaceutiche contenenti progesterone ad elevata biodisponibilita'
FI952377A (fi) Farmaseuttisia ibuprofeenikoostumuksia
FI934387A0 (fi) 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner
FI920845A (fi) Farmaceutiska kompositioner innehaollande interleukin-2
SE9101348D0 (sv) Pharmaceutical composition
SE9103213D0 (sv) Farmaceutisk komposition
ITMI912766A1 (it) Composizione farmaceutica contenente n-acetil-cisteina
SE9202820D0 (sv) Farmaceutisk komposition
ITMI922581A1 (it) Composizione farmaceutica
ITMI922580A0 (it) Composizione farmaceutica
BR9206845A (pt) Composto famacêutico
LV5728A4 (lv) Farmaceitiskas kompozicijas
LV5734A4 (lv) Farmaceitiskas kompozicijas

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees